SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is drawing attention amid a steep selloff across AI data-center and neocloud stocks, as traders debate financing and debt risks and react to Elon Musks comments about stranded compute and tighter funding. Bears question whether capital-intensive operators can execute, while bulls argue that AI demand, power assets, and contracted business remain intact and view the stock as oversold ahead of earnings.

iShares Inc. - iShares MSCI Brazil ETF

iShares MSCI Brazil ETF

Brazils presidential runoff is driving EWZ attention, with traders linking the rally to the markets perceived prospects for a more business-friendly Bolsonaro victory. Bullish call activity and enthusiasm for Brazils gains compete with downside hedging and concerns that election headlines could trigger sharp volatility.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Strong quarterly resultsmarked by accelerating growth and a record profit milestoneare driving attention, with traders cheering the performance and an analyst upgrade. Some remain cautious about credit quality and NUs volatile price action.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention after crudes sharp rally and fresh highs, with traders linking the move to escalating Middle East tensions and perceived risks to oil shipping and infrastructure. Bulls see the supply-risk premium persisting, while bears argue the rally is overextended and could reverse if tensions ease or a deal emerges.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Promising early Phase 1 azer-cel results in progressive MSshowing encouraging safety and disability stabilization or improvementare driving attention, alongside conference updates on BRIUMVIs long-term performance and dosing options. Traders are largely positive about the potential to broaden TG Therapeutics beyond BRIUMVI, while noting the azer-cel evidence is preliminary and expressing disappointment that the stock has not responded more strongly.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

A sharp pullback in gold and GLD is dominating discussion, with traders focused on whether support will hold or the decline will deepen. Bears point to a stronger dollar, rate-hike concerns and selling pressure, while bulls view the weakness as a buying opportunity and question why gold has not acted as a safe haven.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY discussion is focused on volatile, headline-driven trading around reports that Trump said the U.S. would not strike Iran immediately, with traders debating whether that supports a relief bounce or whether persistent conflict and high oil prices keep pressure on equities. The Fed decision, major tech earnings and inflation data are adding to caution, while bullish and bearish views remain sharply divided.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibres latest quarterly results have sparked debate: strong revenue growth and beats on key estimates were overshadowed by falling profit and margin compression, prompting a share selloff. Bulls view the pressure as a consequence of investment in logistics and credit growth, while skeptics question when those investments will translate into stronger profitability.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Traders are focused on the federal cannabis rescheduling process, including the judges rejection of a bid to reopen the hearing and uncertainty over the next steps toward Schedule III. Some view the ruling as progress and are buying the sectors selloff, while others fear further delays; GTBIF holders also debate its weak share performance despite the companys balance sheet and buybacks.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Taus expanding clinical pipeline is driving attention, particularly the FDA-cleared expansion of its recurrent glioblastoma trial and completion of enrollment in its pancreatic cancer study, with further data milestones anticipated. Traders are broadly bullish on the potential catalysts and recent momentum, while some point to thin volume and resistance as reasons for caution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$INVA screens as fairly valued on TickrTrends. It changed from undervalued to fairly valued in this week&#39;s run. Innoviva lists P/E trailing 5x alongside Net margin 80.6%. Informational screening only, not investment advice. Do your own research. https://stocks.tickrtrends.com/inva?utm_source=dlvr.it&amp;utm_medium=stocktwits

Is INVA stock undervalued? Innoviva, Inc. is trading at within about 10% of estimated fair value per TickrTrends' Forward Fair Value model. Updated 2026-10-12.

TickrTrends

INVA - Fairly valued, within about 10% of estimated fair value | TickrTrends

dlvr.it

Innoviva Inc

 screens as fairly valued on TickrTrends. It changed from undervalued to fairly valued in this week's run. Innoviva lists P/E trailing 5x alongside Net margin 80.6%. Informational screening only, not investment advice. Do your own research. 